Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 17, Number 1—January 2011
Dispatch

New Delhi Metallo-β-Lactamase in Klebsiella pneumoniae and Escherichia coli, Canada

Michael R. MulveyComments to Author , Jennifer M. Grant, Katherine Plewes, Diane Roscoe, and David A. Boyd
Author affiliations: Author affiliations: Public Health Agency of Canada, Winnipeg, Manitoba, Canada (M.R. Mulvey, D.A. Boyd); Vancouver General Hospital, Vancouver, British Columbia, Canada (J.M. Grant, K. Plewes, D. Roscoe)

Main Article

Table 2

Antimicrobial drug susceptibilities of the isolates from study of New Delhi metallo-β-lactamase in Klebsiella pneumoniae and Escherichia coli, Canada, 2010*

Test/antimicrobial agent K. pneumoniae
N10–0469 E. coli DH10B
(pNDM-Kp10469) E. coli N10–0505 E. coli DH10B
(pNDM-Ec10505) E. coli DH10B
Broth microdilution (MIC, μg/mL)
Amoxicillin/clavulanic acid >32 >32 32 >32 4
Piercillin/tazobactam >64 >64 >64 >64 <4
Ampicillin >16 >16 >16 >16 2
Cefazolin >16 >16 >16 >16 <8
Cefotaxime >64 >64 >64 >64 <0.25
Cefotaxime/clavulanic acid >64 >64 >64 >64 <0.12
Ceftazidime >128 >128 >128 >128 <0.25
Ceftazidime/clavulanic acid >128 >128 >128 >128 0.25
Cefepime >16 16 >16 16 <1
Cefoxitin >64 >64 >64 >64 8
Imipenem >16 4 2 2 <0.5
Meropenem >8 2 8 2 <1
Chloramphenicol 16 4 32 4 <2
Tetracycline >32 ≤4 32 ≤4 <4
Amikacin >64 >64 >64 >64 2
Gentamicin >16 >16 >16 >16 <0.25
Ciprofloxacin >2 <0.015 >2 <0.015 <0.015
Trimethoprim/sulfamethoxazole
>4
<0.12
>4
<0.12
<0.12
Etest (MIC, μg/mL)
Aztreonam >256 4 >256 4 0.094
Imipenem >32 4 >32 4 0.19
Meropenem >32 8 32 6 0.032
Ertapenem >32 16 >32 16 0.008
Colistin 0.38 ND 0.38 ND ND
Polymyxin B 0.19 ND 0.25 ND ND
Tigecycline
1.5
ND
0.125
ND
ND
Disk diffusion (zone diameter, mm)
Imipenem 6 14 11 13 33
Meropenem 6 15 10 14 35
Ertapenem 6 13 6 13 35

*NDM, New Delhi metallo-β-lactamase; ND, not done.

Main Article

Page created: July 08, 2011
Page updated: July 08, 2011
Page reviewed: July 08, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external